Adam Vogel
Stock Analyst at Craig-Hallum
(4.45)
# 1,124
Out of 4,534 analysts
31
Total ratings
80%
Success rate
34.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Vogel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MPLT MapLight Therapeutics | Maintained: Buy | $43 → $40 | $35.99 | +11.14% | 2 | Jun 23, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $114 → $135 | $134.15 | +0.72% | 6 | Jun 22, 2026 | |
| PEPG PepGen | Initiated Coverage: Buy | $11 | $2.20 | +400.00% | 1 | Jun 16, 2026 | |
| IMNM Immunome | Rated: Buy | $36 | $22.16 | +62.45% | 8 | Jun 11, 2026 | |
| LBRX LB Pharmaceuticals | Rated: Buy | $36 | $30.90 | +16.50% | 4 | Jun 11, 2026 | |
| DSGN Design Therapeutics | Rated: Buy | $15 → $22 | $11.87 | +85.34% | 4 | May 19, 2026 | |
| ACRS Aclaris Therapeutics | Maintained: Buy | $10 | $5.57 | +79.53% | 5 | May 7, 2026 | |
| HIT Health In Tech | Maintained: Buy | n/a | $1.13 | - | 1 | Apr 10, 2026 |
MapLight Therapeutics
Jun 23, 2026
Maintained: Buy
Price Target: $43 → $40
Current: $35.99
Upside: +11.14%
Apogee Therapeutics
Jun 22, 2026
Downgraded: Hold
Price Target: $114 → $135
Current: $134.15
Upside: +0.72%
PepGen
Jun 16, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $2.20
Upside: +400.00%
Immunome
Jun 11, 2026
Rated: Buy
Price Target: $36
Current: $22.16
Upside: +62.45%
LB Pharmaceuticals
Jun 11, 2026
Rated: Buy
Price Target: $36
Current: $30.90
Upside: +16.50%
Design Therapeutics
May 19, 2026
Rated: Buy
Price Target: $15 → $22
Current: $11.87
Upside: +85.34%
Aclaris Therapeutics
May 7, 2026
Maintained: Buy
Price Target: $10
Current: $5.57
Upside: +79.53%
Health In Tech
Apr 10, 2026
Maintained: Buy
Price Target: n/a
Current: $1.13
Upside: -